Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
Add more filters











Publication year range
1.
Intern Emerg Med ; 2024 Jul 19.
Article in English | MEDLINE | ID: mdl-39030397

ABSTRACT

The progressive aging of the population has led to a rise in geriatric pathologies, with sarcopenia, characterized by muscle mass and function loss, becoming a crucial prognostic indicator. This study investigates sarcopenia in elderly hospitalized patients with advanced chronic liver disease (cirrhotic) and non-liver disease patients, comparing their prevalence and exploring correlations with anthropometric and biochemical factors. The cohort of 115 patients, including 50 cirrhotic and 65 non-cirrhotic individuals, exhibited significant comorbidities and a mean age of 78.4 years. Cirrhotic patients presented distinct laboratory parameters indicating liver damage. Applying European Working Group on Sarcopenia in Older People criteria, probable sarcopenia prevalence was similar in cirrhotic (62%) and non-cirrhotic (63%) patients. Stratifying probable sarcopenia into confirmed sarcopenia and dynapenia revealed no significant differences between populations. Correlation analyses demonstrated positive associations between Appendicular Skeletal Muscle Mass (ASM) and anthropometric parameters, malnutrition risk, and grip strength. In cirrhotic patients, muscle mass inversely correlated with liver damage. Odds ratio analysis highlighted the Mini Nutritional Assesment's (MNA) significant predictive capability for sarcopenia. ROC curve analysis affirmed MNA and biochemical markers' combined use, such as transferrin, albumin, total cholesterol, lymphocyte count and C-reactive protein as a strong predictor. Despite limitations, such as a small sample size, this study underscores the significance of thorough sarcopenia screening in elderly hospitalized patients, especially those with cirrhosis. Indeed, individuals with end-stage liver disease are particularly susceptible to sarcopenia. A more personalized approach utilizing tools like MNA and biochemical markers could prove beneficial. Further research is warranted to validate these findings and inform clinical interventions.

2.
Eur Rev Med Pharmacol Sci ; 25(8): 3221-3225, 2021 04.
Article in English | MEDLINE | ID: mdl-33928607

ABSTRACT

Due to early metastasis and delayed diagnosis, lung cancer is the leading cause of cancer-related deaths. Although the most common metastasis sites are brain, bone, lung, adrenal glands, liver, and extra-thoracic lymph node, soft tissues, such as skeletal muscles, skin, and subcutaneous tissues, can also be undermined. This article aims to report the first case of an asymptomatic radial extensor muscle metastasis generating from a lung adenocarcinoma that was diagnosed by ultrasound-guided fine-needle aspiration biopsy (FNAB).


Subject(s)
Adenocarcinoma of Lung/diagnosis , Endoscopic Ultrasound-Guided Fine Needle Aspiration , Lung Neoplasms/diagnosis , Upper Extremity/pathology , Aged , Humans , Male
3.
J Nutr Health Aging ; 24(7): 717-722, 2020.
Article in English | MEDLINE | ID: mdl-32744567

ABSTRACT

Nutritional alterations are highly prevalent in older rather than adult hospitalized patients. In these subjects, a loss of physical performance is dependent on the impairment of muscle architecture. This study aimed to investigate the association between the nutritional status and muscle architecture in elderly patients hospitalized in internal medicine wards. 68 aged patients admitted in internal medicine wards were consecutively enrolled and stratified in three groups based on the Mini Nutritional Assessment (MNA) score: well-fed (WF), at risk of malnutrition (RM), and malnourished (M). Biochemical indices and anthropometric parameters were sampled at hospital admission. Furthermore, all patients were assessed at admission and after 7 days of hospitalization for muscle strength (hand-grip test), mass (bioimpedentiometry), and architecture (ultrasonography of vastus lateralis). At hospital admission, M patients showed lower percentage of fat free mass and muscle mass with respect to WF and RM. Furthermore, M group presented with lower muscle thickness and pennation angle, as compared to WF and RM. At admission, the MNA score was positively related to the pennation angle and muscle strength. Multivariate linear regression analysis showed that the nutritional status at admission was the only significant factor influencing pennation angle. Finally, during the first 7 days of hospitalization, a decrease of pennation angle occurred in all the groups studied. We conclude that malnutrition at admission is associated with impaired muscle architecture in elderly patients hospitalized in internal medicine wards. Moreover, muscle architecture is impacted by early hospitalization, irrespective of nutritional status.


Subject(s)
Muscles/anatomy & histology , Nutrition Assessment , Nutritional Status/physiology , Aged , Female , Hospitalization , Humans , Internal Medicine , Male , Malnutrition , Prevalence
4.
Eur J Obstet Gynecol Reprod Biol ; 218: 99-105, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28963923

ABSTRACT

OBJECTIVE: The study aimed to explore the type 1 and type 2 cytokines expression in the endometrium from women affected by endometriosis compared to controls. The expression of TSG-6, a multifunctional protein involved in several inflammatory disease, was also evaluated. Study Design SETTING: Experimental clinical study. PATIENTS: 10 patients affected by endometriosis and 11 controls. INTERVENTIONS: Patients underwent to an ultrasound transvaginal examination and a diagnostic hysteroscopy in order to exclude any uterine abnormality. All patients underwent endometrial biopsy using a Novak's curette. MAIN OUTCOME MEASURES: The endometrial expression of type 1 (IL- 1 ß TNF-α, IL-8) and type 2 (IL-10) cytokines, and of TSG-6 was evaluated by immunohistochemistry and by real time PCR. The expression of TSG-6 was confirmed by western blot. RESULTS: Results of PCR analysis and of immunohistochemistry revealed an increased expression of IL-1ß, TNF-α, IL-8 and of TSG-6 in the endometrium of endometriosic patients. IL-10 expression did not show any difference. CONCLUSIONS: An increased expression of pro-inflammatory type 1 cytokines was demonstrated in the endometrium from endometriosic patients, suggesting an endometrial environment harmful for implantation due to the prevalence of Th1 related immunity. An increased expression of TSG-6 was also demonstrated for the first time. Our findings concur to better define the inflammatory imbalance and the abnormal endometrial receptivity, reported in literature, of the eutopic endometrium of women affected by endometriosis.


Subject(s)
Endometriosis/metabolism , Endometrium/metabolism , Infertility, Female/immunology , Adult , Blotting, Western , Case-Control Studies , Cell Adhesion Molecules/genetics , Cell Adhesion Molecules/metabolism , Endometrium/cytology , Female , Gene Expression Regulation , Humans , Inflammation Mediators/immunology , Interleukin-10/metabolism , Interleukin-1alpha/genetics , Interleukin-1alpha/metabolism , Interleukin-1beta/metabolism , Interleukin-8/metabolism , RNA, Messenger/metabolism , Real-Time Polymerase Chain Reaction , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism , Ultrasonography , Young Adult
5.
Free Radic Res ; 47(11): 881-93, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24000796

ABSTRACT

Oxysterols are oxidized species of cholesterol coming from exogenous (e.g. dietary) and endogenous (in vivo) sources. They play critical roles in normal physiologic functions such as regulation of cellular cholesterol homeostasis. Most of biological effects are mediated by interaction with nuclear receptor LXRα, highly expressed in the liver as well as in many other tissues. Such interaction participates in the regulation of whole-body cholesterol metabolism, by acting as "lipid sensors". Moreover, it seems that oxysterols are also suspected to play key roles in several pathologies, including cardiovascular and inflammatory disease, cancer, and neurodegeneration. Growing evidence suggests that oxysterols may contribute to liver injury in non-alcoholic fatty liver disease. The present review focuses on the current status of knowledge on oxysterols' biological role, with an emphasis on LXR signaling and oxysterols' physiopathological relevance in NAFLD, suggesting new pharmacological development that needs to be addressed in the near future.


Subject(s)
Fatty Liver/metabolism , Receptors, Steroid/metabolism , Animals , Humans , Lipid Metabolism , Non-alcoholic Fatty Liver Disease , Oxidation-Reduction , Signal Transduction
6.
Clin Exp Immunol ; 172(2): 254-62, 2013 May.
Article in English | MEDLINE | ID: mdl-23574322

ABSTRACT

To characterize the repertoire of T lymphocytes in chronically hepatitis C virus (HCV)-infected patients with and without mixed cryoglobulinaemia (MC). T cell receptor (TCR) variable (V) ß clonalities in portal tracts isolated from liver biopsy sections with a laser capture microdissection technique in 30 HCV-positive MC patients were studied by size spectratyping. Complementarity-determining region 3 (CDR3) profiles of liver-infiltrating lymphocytes (LIL) were also compared with those circulating in the blood. The representative results of TCR Vß by CDR3 were also obtained from liver tissues and peripheral blood lymphocytes (PBL) of 21 chronically HCV-infected patients without MC. LIL were highly restricted, with evidence of TCR Vß clonotypic expansions in 23 of 30 (77%) and in 15 of 21 (71%) MC and non-MC patients, respectively. The blood compartment contained TCR Vß expanded clones in 19 (63%) MC and 12 (57%) non-MC patients. The occurrence of LIL clonalities was detected irrespective of the degree of liver damage or circulating viral load, whereas it correlated positively with higher levels of intrahepatic HCV RNA. These results support the notion that TCR Vß repertoire is clonally expanded in HCV-related MC with features comparable to those found in chronically HCV-infected patients without MC.


Subject(s)
Complementarity Determining Regions/immunology , Cryoglobulinemia/immunology , Genetic Diseases, Inborn/immunology , Hepatitis C, Chronic/immunology , Receptors, Antigen, T-Cell, alpha-beta/genetics , T-Lymphocytes/immunology , Aged , Cryoglobulinemia/complications , Cryoglobulinemia/virology , Female , Gene Rearrangement , Genetic Diseases, Inborn/complications , Genetic Diseases, Inborn/virology , Genetic Variation , Hepacivirus/immunology , Hepatitis C, Chronic/complications , Humans , Laser Capture Microdissection , Leukocytes, Mononuclear/immunology , Liver/immunology , Liver/virology , Male , Middle Aged , RNA, Viral , Viral Load
7.
Clin Dev Immunol ; 2012: 849373, 2012.
Article in English | MEDLINE | ID: mdl-22966241

ABSTRACT

Host genetic factors may predict the outcome and treatment response in hepatitis C virus (HCV) infection. Very recently, three landmark genome-wide association studies identified single nucleotide polymorphisms near the interleukin 28B (IL28B) region which were more frequent in responders to treatment. IL28B encodes interferon (IFN)λ3, a type III IFN involved in host antiviral immunity. Favourable variants of the two most widely studied IL28B polymorphisms, rs12979860 and rs8099917, are strong pretreatment predictors of early viral clearance and sustained viral response in patients with genotype 1 HCV infection. Further investigations have implicated IL28B in the development of chronic HCV infection versus spontaneous resolution of acute infection and suggest that IL28B may be a key factor involved in host immunity against HCV. This paper presents an overview about the biological activity and clinical applications of IL28B, summarizing the available data on its impact on HCV infection. Moreover, the potential usefulness of IFNλ in the treatment and natural history of this disease is also discussed.


Subject(s)
Hepacivirus/drug effects , Hepatitis C/drug therapy , Hepatitis C/genetics , Interleukins/genetics , Polymorphism, Single Nucleotide , Antiviral Agents/therapeutic use , Hepacivirus/immunology , Hepatitis C/immunology , Hepatitis C/virology , Humans , Interferons , Treatment Outcome
8.
Curr Med Chem ; 19(33): 5647-57, 2012.
Article in English | MEDLINE | ID: mdl-22856655

ABSTRACT

Drug use is seen more as an individualistic behaviour and is therefore not readily conceived of from a population perspective. There is general recognition of several phases and degrees of drug abuse, from initiation and early-use patterns to long-term chronic use. Cocaine and its derivative "crack" cocaine provide an example of both the globalization of substance use and the cyclical nature of drug epidemics. Cocaine is a powerful CNS (Central Nervous System) stimulant but exerts its action in a several types of adverse health effects, including acute toxic effects (i.e. overdose, accidental injury and violence), dependence, cardiovascular disease, cirrhosis, bloodborne bacterial and viral infections, and mental disorders. Of interest, many people who use Cocaine will use also other drugs; therefore, ascribing adverse health effect to a certain drug might be difficult. Any mucous membrane can act as a port of entry for cocaine and the systemic effect is greatly influenced by the route and speed of administration. The effects of Cocaine mainly depend on the user's addiction, the dose received and the mode of assumption. Laws restricting the availability of cocaine saw a decrease in consumption in these countries until the 1960s. The number of cocaine users worldwide ranged from 14 million to 21 million (0.3-0.5% of the population aged 15-64 years). The largest market was North America, then western and central Europe and South America.


Subject(s)
Central Nervous System Stimulants/adverse effects , Cocaine-Related Disorders/complications , Cocaine-Related Disorders/epidemiology , Cocaine/adverse effects , Dopamine Uptake Inhibitors/adverse effects , Animals , Cardiovascular Diseases/chemically induced , Cardiovascular Diseases/etiology , Cardiovascular Diseases/pathology , Cardiovascular System/drug effects , Cardiovascular System/pathology , Central Nervous System Stimulants/pharmacokinetics , Central Nervous System Stimulants/pharmacology , Cocaine/pharmacokinetics , Cocaine/pharmacology , Dopamine Uptake Inhibitors/pharmacokinetics , Dopamine Uptake Inhibitors/pharmacology , Humans , Lung/drug effects , Lung/pathology
9.
Curr Med Chem ; 17(22): 2325-37, 2010.
Article in English | MEDLINE | ID: mdl-20491641

ABSTRACT

Mitochondrial dysfunction acts as a common pathogenetic mechanism in several acute and chronic liver diseases, such as Alcoholic and Non-Alcoholic Fatty Liver Disease (NAFLD), drug-induced steatohepatitis, viral hepatitis, biliary cirrhosis, hepatocellular carcinoma, ischemia/reperfusion injury and transplant rejection. In particular mitochondrial uncoupling,has been recently identified to play a determinant role in the pathogenesis of liver diseases by causing decrease of mitochondrial proton motive force and ATP depletion. Damaged mitochondria present defects in lipid homeostasis, bioenergetics impairment and overproduction of Reactive Oxygen Species (ROS), leading to lipid accumulation and oxidative stress. Dysfunctional and/or uncoupled mitochondria enhance the susceptibility of hepatocytes to cell death by necrosis, via ATP depletion, or by apoptosis, via membrane permeabilization. Thus, prevention of mitochondrial alterations promises to be an effective strategy for treatment of liver diseases. However, no therapy has proven to be absolutely effective, whereas those that are beneficial present several side effects. The present review summarizes the recent approaches in mitochondrial drug deliver systems and focuses on mitochondria-targeted molecules application in liver disease. New selective molecules and nanocarriers technology are also considered as potentially effective in the targeting of mitochondrial dysfunction in liver pathology.


Subject(s)
Drug Delivery Systems/methods , Liver Diseases/drug therapy , Mitochondria/drug effects , Animals , Cell Death/physiology , Humans , Liver Diseases/metabolism , Liver Diseases/pathology , Mitochondria/metabolism , Mitochondria/pathology , Oxidative Stress/drug effects , Reactive Oxygen Species/metabolism
10.
Int J Immunopathol Pharmacol ; 22(3): 819-27, 2009.
Article in English | MEDLINE | ID: mdl-19822098

ABSTRACT

Frailty syndrome (FS) is a condition described in aging and characterized by physical vulnerability to stress and lack of physiological reserve. In this study we aim to define whether circulating oxidative stress correlates to frailty in terms of glutathione balance and oxidative protein damage. In 62 elderly outpatients, classified as frail patients according to Fried's criteria, evaluation of reduced glutathione (GSH), oxidized glutathione (GSSG), tumor necrosis factor-alpha, malonaldehyde-(MDA) and 4-hydroxy-2,3-nonenal-(HNE) protein plasma adducts were performed. A significant increase in the GSSG was observed in patients with FS when compared to non-frail. No difference was shown in the GSH amount, suggesting a glutathione oxidation more than impairment of the synthesis. TNF-alpha, MDA- and HNE-adducts, were significantly higher in FS as compared to non-frail patients. A logistic regression model correlating FS with redox balance showed a close relationship between glutathione ratio (OR=1.8, 95% CI=1.2-2.5) and MDA adducts (OR=2.8, 95% CI=1.6-4.7) to frailty. Our findings show an association between oxidative imbalance and Frailty Syndrome. GSSG/GSH ratio and plasma protein adducts strongly predict the frailty conditions and seem to be reliable and easily measurable markers in the context of the multidimensional analysis of elderly patients.


Subject(s)
Aging/blood , Frail Elderly , Glutathione/blood , Oxidative Stress , Aged , Aged, 80 and over , Aldehydes/blood , Biomarkers/blood , Case-Control Studies , Female , Glutathione Disulfide/blood , Humans , Inflammation Mediators/blood , Lipid Peroxidation , Logistic Models , Male , Malondialdehyde/blood , Odds Ratio , Oxidation-Reduction , Risk Assessment , Risk Factors , Syndrome , Tumor Necrosis Factor-alpha/blood
11.
Gut ; 57(7): 957-65, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18308829

ABSTRACT

BACKGROUND: The mechanisms of progression from fatty liver to steatohepatitis and cirrhosis are not well elucidated. Mitochondrial dysfunction represents a key factor in the progression of non-alcoholic steatohepatitis (NASH) as mitochondria are the main cellular site of fatty acid oxidation, ATP synthesis and reactive oxygen species (ROS) production. AIMS: (1) To evaluate the role of the uncoupling protein 2 in controlling mitochondrial proton leak and ROS production in NASH rats and humans; and (2) to assess the acute liver damage induced by ischaemia-reperfusion in rats with NASH. METHODS: Mitochondria were extracted from the livers of NASH humans and rats fed a methionine and choline deficient diet. Proton leak, H(2)O(2) synthesis, reduced glutathione/oxidised glutathione, 4-hydroxy-2-nonenal (HNE)-protein adducts, uncoupling protein-2 (UCP2) expression and ATP homeostasis were evaluated before and after ischaemia-reperfusion injury. RESULTS: NASH mitochondria exhibited an increased rate of proton leak due to upregulation of UCP2. These results correlated with increased production of mitochondrial hydrogen peroxide and HNE-protein adducts, and decreased hepatic ATP content that was not dependent on mitochondrial ATPase dysfunction. The application of an ischaemia-reperfusion protocol to these livers strongly depleted hepatic ATP stores, significantly increased mitochondrial ROS production and impaired ATPase activity. Livers from patients with NASH exhibited UCP2 over-expression and mitochondrial oxidative stress. CONCLUSIONS: Upregulation of UCP2 in human and rat NASH liver induces mitochondrial uncoupling, lowers the redox pressure on the mitochondrial respiratory chain and acts as a protective mechanism against damage progression but compromises the liver capacity to respond to additional acute energy demands, such as ischaemia-reperfusion. These findings suggest that UCP2-dependent mitochondria uncoupling is an important factor underlying events leading to NASH and cirrhosis.


Subject(s)
Fatty Liver/complications , Ion Channels/physiology , Liver/blood supply , Mitochondria, Liver/metabolism , Mitochondrial Proteins/physiology , Reperfusion Injury/etiology , Acute Disease , Adenosine Triphosphatases/metabolism , Adenosine Triphosphate/deficiency , Adult , Aldehydes/metabolism , Animals , Disease Progression , Fatty Liver/metabolism , Female , Humans , Ion Channels/metabolism , Liver/metabolism , Male , Membrane Potential, Mitochondrial , Middle Aged , Mitochondrial Proteins/metabolism , Oxidative Stress , Rats , Rats, Wistar , Reactive Oxygen Species/metabolism , Reperfusion Injury/metabolism , Uncoupling Protein 2
12.
Eur J Clin Invest ; 38(4): 245-52, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18339004

ABSTRACT

BACKGROUND: Mitochondrial dysfunction is considered a key player in non-alcoholic steatohepatitis (NASH) but no data are available on the mitochondrial function and ATP homeostasis in the liver during NASH progression. In the present paper we evaluated the hepatic mitochondrial respiratory chain activity and ATP synthesis in a rodent model of NASH development. MATERIALS AND METHODS: Male Wistar rats fed a High Fat/Methionine-Choline Deficient (MCD) diet to induce NASH or a control diet (SHAM), and sacrificed after 3, 7 and 11 weeks. The oxidative phosphorylation, the F(0)F(1)ATPase (ATP synthase) and the ATP content were assessed in liver mitochondria. RESULTS: NASH mitochondria exhibited an increased rate of substrate oxidation at 3 weeks, which returned to below the normal level at 7 and 11 weeks, concomitantly with the coupling between the phosphorylation activity and the mitochondrial respiration (ADP/O). Uncoupling of NASH liver mitochondria did not allow the recovery of the maximal respiration rate at 7 and 11 weeks. The ATPase (ATP synthase) activity was similar in NASH and SHAM rats, but the mitochondrial ATP content was significantly lower in NASH livers. CONCLUSIONS: The loss of hepatic ATP stores is not dependent on the F(0)F(1)-ATPase but resides in the respiratory chain. Dysfunction of both Complex I and II of the mitochondrial respiratory chain during NASH development implies a mitochondrial adaptive mechanism occurring in the early stages of NASH.


Subject(s)
Adenosine Triphosphate/metabolism , Fatty Liver/metabolism , Mitochondria, Liver/metabolism , Alanine Transaminase/metabolism , Animals , Choline Deficiency/metabolism , Hepatitis/metabolism , Homeostasis/physiology , Male , Mitochondrial Diseases/metabolism , Oxidative Phosphorylation , Polymerase Chain Reaction , Rats , Rats, Wistar
13.
Int J Immunopathol Pharmacol ; 20(3): 585-93, 2007.
Article in English | MEDLINE | ID: mdl-17880771

ABSTRACT

We studied the effects of Propofol, Desflurane, and Sevoflurane on the systemic redox balance in patients undergoing laparohysterectomy. We measured blood concentration of glutathione (GSH), plasma antioxidant capacity (Trolox Equivalent Antioxidant Capacity-TEAC), and lipid peroxidation products (malondialdehyde (aMDA) and 4-hydroxynonenal (aHNE) protein adducts). Sixty patients were randomly placed into three groups of twenty people each. In Group P anesthesia was induced with Propofol 2 mg/kg and maintained with 12-10-8 mg/kg/min; in Groups S and D anesthesia was induced with 3 mg/kg Sodium Thiopental and maintained with 2 percent Sevoflurane and 6 percent Desflurane, respectively. Blood samples were collected prior to induction (T0 bas), 60min and 24h postoperatively (T1 60 and T2 24 h). In Group P, GSH increased on T1 60 and returned to baseline on T24h, while TEAC remained unmodified; in Groups S, GSH and TEAC decreased on T1 60 in Group D, on T1 60 there was a slight decrease of GSH and TEAC. The levels of aMDA slightly decreased throughout the study periods in Group P, increased in Group D, and remained stable in Group S. Propofol showed antioxidant properties, while Sevoflurane and Desflurane seemed to shift the redox balance towards oxidation, yet without inducing overt oxidative damage.


Subject(s)
Anesthetics, Inhalation/adverse effects , Anesthetics, Intravenous/adverse effects , Isoflurane/analogs & derivatives , Lipid Peroxidation/drug effects , Methyl Ethers/adverse effects , Propofol/adverse effects , Anesthetics, Inhalation/therapeutic use , Anesthetics, Intravenous/therapeutic use , Desflurane , Humans , Isoflurane/adverse effects , Isoflurane/therapeutic use , Laparoscopy , Lipid Peroxides/blood , Methyl Ethers/therapeutic use , Middle Aged , Propofol/therapeutic use , Sevoflurane
14.
Redox Rep ; 12(1): 91-5, 2007.
Article in English | MEDLINE | ID: mdl-17263918

ABSTRACT

Aging is associated with a decline in performance in many organs and loss of physiological performance can be due to free radicals. Mitochondria are incompletely coupled: during oxidative phosphorylation some of the redox energy is dissipated as natural proton leak across the inner membrane. To verify whether proton leak occurs in mitochondria during aging, we measured the mitochondrial respiratory chain activity, membrane potential and proton leak in liver, kidneys and heart of young and old rats. Mitochondria from old rats showed normal rates of Complex I and Complex II respiration. However, they had a lower membrane potential compared to mitochondria from younger rats. In addition, they exhibited an increased rate of proton conductance which partially dissipated the mitochondrial membrane potential when the rate of electron transport was suppressed. This could compromise energy homeostasis in aging cells in conditions that require additional energy supply and could minimize oxidative damage to DNA.


Subject(s)
Aging/physiology , Kidney/physiology , Mitochondria, Heart/physiology , Mitochondria, Liver/physiology , Mitochondria/physiology , Animals , DNA Damage , Heart/growth & development , Kidney/growth & development , Liver/growth & development , Oxygen Consumption , Rats
15.
Int J Immunopathol Pharmacol ; 19(3): 617-28, 2006.
Article in English | MEDLINE | ID: mdl-17026847

ABSTRACT

The mechanism responsible for the reversibility of airflow limitation in stable chronic obstructive pulmonary disease (COPD) patients is unknown. The aim of this study is to assess the relationship between the reversibility of airflow limitation, the redox balance and the inflammatory cells in the sputum of patients with stable COPD. For this purpose we examined 15 normal healthy control subjects and 20 nonatopic COPD patients. The COPD patients were divided into two groups: reversible COPD (increase in FEV1> 200 ml and/or > or =12> or = after 200 microg of inhaled salbutamol) or non-reversible COPD. GSH, GSSG were measured in induced sputum and blood. Protein carbonyls were evaluated by WB in sputum and IL-4 and IL-6 and TNF-alpha in plasma and sputum. GSH oxidation and protein oxidation were lower in reversible COPD patients than in those with no reversibility. The sputum eosinophil count was significantly higher in the reversible group than in the non-reversible group, and IL-4 concentration was higher in the same patients both in sputum and in plasma. In contrast, IL-6 and TNF-alpha were increased in non-reversible COPD patients in both biological samples. We conclude that airflow reversibility in COPD patients is associated with airway oxidative stress and activation of eosinophil inflammatory pattern in sputum and blood, suggesting that these patients could respond to specific pharmacological treatment.


Subject(s)
Oxidative Stress , Pulmonary Disease, Chronic Obstructive/metabolism , Sputum/metabolism , Adult , Cytokines/biosynthesis , Female , Forced Expiratory Volume , Glutathione/metabolism , Humans , Male , Middle Aged , Neutrophils/metabolism , Nitric Oxide/physiology , Pulmonary Disease, Chronic Obstructive/pathology , Sputum/cytology , Superoxides/metabolism
16.
Dig Liver Dis ; 37(9): 689-97, 2005 Sep.
Article in English | MEDLINE | ID: mdl-15935746

ABSTRACT

BACKGROUND AND AIMS: Oxidative stress contributes to ischemia-reperfusion injury in fatty livers. This study aimed to determine whether glycogen depletion influences this oxidative injury and whether the administration of glucose can be protective. METHODS: Rats with choline deficiency-induced fatty liver underwent hepatic ischemia-reperfusion. Experimental groups: (1) fed rats; (2) 18 h fasted rats; (3) 18 h fasted rats supplemented with glucose prior to surgery. The thiobarbituric acid-reactive substances, protein carbonyls and total glutathione concentrations were measured in liver tissue and isolated mitochondria as parameters of oxidative stress before and after ischemia and during reperfusion. The mitochondrial F1-ATPase content and the serum alanine transaminase were also determined. RESULTS: With respect to fed rats, fasted rats exhibited an increased oxidative injury in both liver tissue and isolated mitochondria throughout the experiment with the only exception of thiobarbituric acid-reactive substances, which were not affected by the nutritional status in liver tissue. Fasted rats showed a significantly lower F1-ATPase content and higher alanine transaminase levels. Glucose supplementation significantly reduced the fasting-associated exacerbation of oxidative stress and liver injury and the F1-ATPase exhaustion. CONCLUSIONS: These data indicate that the pre-existing hepatic glycogen content modulates the oxidative damage in rat fatty livers exposed to ischemia-reperfusion injury and that the energetic substrate supplementation may represent a clinically feasible protective strategy.


Subject(s)
Fatty Liver/pathology , Glucose/pharmacology , Oxidative Stress/physiology , Reperfusion Injury/physiopathology , Alanine Transaminase/blood , Alanine Transaminase/metabolism , Animals , Dietary Supplements , Fatty Liver/metabolism , Glucose/administration & dosage , Glutathione/metabolism , Liver/drug effects , Liver/metabolism , Liver/pathology , Male , Nutritional Status , Oxidative Stress/drug effects , Protein Carbonylation , Proton-Translocating ATPases/metabolism , Rats , Rats, Sprague-Dawley , Reperfusion Injury/prevention & control , Thiobarbituric Acid Reactive Substances/metabolism
17.
J Clin Endocrinol Metab ; 87(6): 2843-8, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12050261

ABSTRACT

This study aimed to evaluate the effects of changes in sex hormones occurring during the menstrual cycle on the redox balance and lipid peroxidation in normal human endometrial cells. Forty women, ages 21-41 yr, who were admitted to the Department of Gynecology and Obstetrics of the University of Bari for routine checkups or were treated for benign uterine disease, underwent endometrial biopsy and venipuncture. On the basis of histological examination, patients were allocated as follows: 10 in the early proliferative phase, 12 in the late proliferative phase, 8 in the early secretory phase, and 10 in the late secretory phase. LH, FSH (immunoradiometric essay), estradiol (E2), and progesterone (P(4)) (RIA) were determined in plasma samples. On the endometrial specimens, total glutathione (GSH), oxidized GSH (GSSG), malondialdehyde, and GSH peroxidase activity (GSH-Px) were determined. Significant cycle-dependent changes in endometrial GSH-Px (P < 0.0001), GSH (P < 0.001), and GSSG as a percentage of GSH (P < 0.0001) were observed. Malondialdehyde did not show significant differences. A linear regression model correlating sex hormone changes with redox indexes was performed. A significant positive correlation was observed between E2 and GSH-Px (r = 0.74; P = 0.0001), E2 and GSSG, as percentage of total (r = 0.84; P < 0.0001); a negative correlation was found between E2 and GSH (r = -0.57; P = 0.0001). No significant correlation was found between P(4) or FSH and oxidative balance. LH was found to be correlated with GSH-Px (r = 0.66; P = 0.0001) and GSSG as percentage of GSH (r = 0.5; P < 0.001). We conclude that the hormonal pattern is involved in maintaining the optimal redox balance in endometrium, mainly through modulation of GSH level and metabolism.


Subject(s)
Endometrium/metabolism , Gonadal Steroid Hormones/metabolism , Menstrual Cycle/metabolism , Adult , Endometrium/cytology , Estradiol/metabolism , Female , Glutathione/metabolism , Glutathione Disulfide/metabolism , Glutathione Peroxidase/metabolism , Humans , Luteinizing Hormone/metabolism , Malondialdehyde/metabolism , Oxidation-Reduction
18.
Gut ; 50(3): 361-7, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11839715

ABSTRACT

BACKGROUND: During neoplastic progression, alterations in transforming growth factor beta1 (TGF-beta1) dependent control of cell growth may be an important mechanism of selective proliferation of transformed cellular clones. Defective regulation of TGF-beta1 receptors has been reported to occur in a number of human malignant tumours while little is known of the actual levels of this growth inhibitory cytokine in cancer. On the basis of the demonstrated ability of major lipid peroxidation products such as 4-hydroxynonenal to modulate TGF-beta1 expression and synthesis, we speculated that decreased lipid oxidation, as frequently observed in neoplastic tissues, would contribute to the selective promotion of tumour growth through decreased expression of the cytokine within the tumour mass. AIMS: To seek a possible association between steady state levels of major aldehydic end products of lipid peroxidation and TGF-beta1 content in human colon cancer at different stages of growth. PATIENTS AND METHODS: Tissue biopsies from 15 adult patients with colon adenocarcinoma of different TNM and G stagings were compared with regard to lipid peroxidation aldehydes and net TGF-beta1 levels. For a more comprehensive analysis, cytokine type I and II receptors were measured in tumour biopsies. In one set of experiments, to support the conclusions, the apoptotic effect of TGF-beta1 was evaluated in a human colon cancer cell line, CaCo-2, retaining receptor changes consistent with those observed in cancer patients. RESULTS: With the exception of two extremely advanced cases (T4/G3) in which tissue levels of lipid peroxidation were within the normal range, 4-hydroxynonenal was significantly decreased in all other cancer specimens. Consistent with lipid peroxidation levels, TGF-beta1 protein was markedly decreased or even negligible compared with the corresponding normal tissue surrounding the tumour in all tested biopsies except for the two T4/G3 colon cancers in which cytokine content was again within the normal range. As regards TGF-beta1 receptors, both in tumour sections and CaCo-2 cells, downregulation was greater for TGF-beta1 receptor I than for receptor II. Of note, in CaCo-2 cells, incubation with appropriate doses of TGF-beta1 led to marked nuclear fragmentation and apoptosis. CONCLUSIONS: Evasion of human colon cancer cells from TGF-beta1 mediated growth inhibition appears to be due not only to downregulation of TGF-beta1 receptors, which is inconsistent and unrelated to cancer development, but also to the constant low concentration of this cytokine in the tumour mass. The associated levels of lipid peroxidation aldehydes, much lower than in control tissue, probably represent a lower stimulus for TGF-beta1 production in the neoplastic area and thus a favourable condition for neoplastic progression.


Subject(s)
Adenocarcinoma/metabolism , Colonic Neoplasms/metabolism , Lipid Peroxidation/physiology , Neoplasm Proteins/metabolism , Transforming Growth Factor beta/metabolism , Adenocarcinoma/pathology , Aged , Aged, 80 and over , Apoptosis , Caco-2 Cells , Colonic Neoplasms/pathology , Disease Progression , Female , Humans , Intestinal Mucosa/metabolism , Male , Malondialdehyde/analysis , Middle Aged , Receptors, Transforming Growth Factor beta/metabolism , Transforming Growth Factor beta1
19.
Toxicol Lett ; 123(2-3): 209-16, 2001 Sep 15.
Article in English | MEDLINE | ID: mdl-11641048

ABSTRACT

Mitochondrial oxidative balance and myocardial fibrosis were investigated in pair-fed rats received ethanol (3%) or saccharose in drinking water for 8 weeks. The concentrations of glutathione, malondialdehyde, protein carbonyls and sulfhydrils were determined. The presence and distribution of fibronectin were detected by immunohistochemistry. The myocardial concentrations of reduced glutathione and protein sulfhydrils were lower in ethanol treated rats. The oxidised/reduced glutathione ratio, the levels of malondialdehyde and protein carbonyls were higher in ethanol-treated rats. The mitochondrial amount of proteins, glutathione and protein sulfhydrils were lower in ethanol treated rats, whereas the content of protein carbonyls and malondialdehyde were higher. Accumulation of fibronectin was detected at subepicardial and subendocardial districts in ethanol-treated rats, with moderate degree of fibrosis in 20% of the cases. In conclusion, moderate ethanol consumption is associated with oxidative damage to heart mitochondria and fibronectin deposition. These oxidative and ultrastuctural changes may be assumed as basic alterations in the development of alcoholic cardiomyopathy.


Subject(s)
Cardiomyopathies/pathology , Ethanol/toxicity , Mitochondria, Heart/drug effects , Administration, Oral , Alcoholism/complications , Animals , Body Weight/drug effects , Cardiomyopathies/blood , Cardiomyopathies/etiology , Drug Administration Schedule , Ethanol/administration & dosage , Ethanol/blood , Fibronectins/metabolism , Fibrosis , Glutathione/metabolism , Heart Atria/drug effects , Heart Atria/metabolism , Heart Atria/pathology , Heart Ventricles/drug effects , Heart Ventricles/metabolism , Heart Ventricles/pathology , Immunohistochemistry , Ketones/metabolism , Male , Malondialdehyde/metabolism , Mitochondria, Heart/pathology , Myocardium/metabolism , Myocardium/pathology , Organ Size/drug effects , Oxidation-Reduction/drug effects , Oxidative Stress , Rats , Rats, Wistar , Sulfhydryl Compounds/metabolism
20.
Toxicol Appl Pharmacol ; 175(2): 130-9, 2001 Sep 01.
Article in English | MEDLINE | ID: mdl-11543645

ABSTRACT

Oxidative stress may represent a common link between chronic liver damage and hepatic fibrosis. Antioxidants and interferon seem to protect against hepatic stellate cell (HSC) activation and liver fibrosis. This study evaluated (1) the effect of the profibrotic agent dimethylnitrosamine (DMN) on the hepatic oxidative balance in the rat; (2) the role played by the antioxidant agent N-acetylcysteine (NAC); and (3) the antifibrotic effects of two different types of interferon-alpha: recombinant alpha-2b (rIFN-alpha) and leukocyte alpha (LeIFN-alpha). Five groups of rats received: (1) saline; (2) DMN; (3) DMN + NAC; (4) DMN + rIFN-alpha; and (5) DMN + LeIFN-alpha. Oxidative balance was evaluated by hepatic glutathione, TBARs, protein carbonyl, and sulfhydryl determination. Fibrosis was determined by hepatic hydroxyproline content and fibronectin (FN) staining (immunohistochemistry). DMN rats showed a diffuse FN deposition, an impaired oxidative balance, and higher hepatic hydroxyproline levels compared to that of controls. NAC administration significantly reduced FN deposition, increased hepatic glutathione, and decreased TBARs and protein carbonyls. Administration of IFN-alpha exerted different effects according to the type used. Both IFNs decreased FN deposition; however, LeIFN-alpha significantly improved histology and oxidative parameters compared to those of untreated DMN and rats treated with rIFN-alpha. This study shows the role of free radicals in this model of hepatic fibrosis; the protective effect of NAC against liver fibrosis; and the antifibrotic effect exerted by IFN-alpha (particularly LeIFN-alpha) independent of its antiviral activity.


Subject(s)
Dimethylnitrosamine/toxicity , Liver Cirrhosis/chemically induced , Liver Cirrhosis/prevention & control , Oxidative Stress/drug effects , Acetylcysteine/therapeutic use , Animals , Free Radical Scavengers/therapeutic use , Interferon-alpha/therapeutic use , Liver Cirrhosis/metabolism , Liver Cirrhosis/pathology , Male , Rats , Rats, Wistar , Thiobarbituric Acid Reactive Substances/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL